Free shipping on all orders over $ 500

PD173955

Cat. No. M2917
PD173955 Structure
Size Price Availability Quantity
1mg USD 85  USD85 In stock
2mg USD 100  USD100 In stock
5mg USD 170  USD170 In stock
10mg USD 270  USD270 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

PD173955 is a potent Bcr-Abl inhibitor with IC50 of 1-2 nM, also inhibiting Src activity with IC50 of 22 nM.

Customer Product Validations & Biological Datas
Source Vascul Pharmacol (2013). Figure 1. PD173955
Method western blot
Cell Lines HAECs
Concentrations 5 μM
Incubation Time 30 min
Results PD173955 and PP2 suppressed PLC-induced increase in eNOS phosphorylation and activity.
Chemical Information
Molecular Weight 443.35
Formula C21H16Cl2N4OS
CAS Number 260415-63-2
Solubility (25°C) DMSO 15 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Anjana Sinha, et al. Development of Kinase Inactive PD173955 Analogues for Reducing Production of Aβ Peptides

[2] Robert Roskoski Jr. A historical overview of protein kinases and their targeted small molecule inhibitors

[3] George A Kraus, et al. New effective inhibitors of the Abelson kinase

[4] Sandra W Cowan-Jacob, et al. Imatinib (STI571) resistance in chronic myelogenous leukemia: molecular basis of the underlying mechanisms and potential strategies for treatment

[5] Bhushan Nagar, et al. Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571)

Related Src-bcr-Abl Products
Asciminib hydrochloride

Asciminib (ABL001) hydrochloride is a potent and selective allosteric BCR-ABL1 inhibitor, which inhibits Ba/F3 cells grown with an IC50 of 0.25 nM.

Osteogenic Growth Peptide (10-14)

Osteogenic Growth Peptide (10-14) (OGP(10-14)), the C-terminal truncated pentapeptide of osteogenic growth peptide (OGP), retains the full OGP-like activity.

Abl Cytosolic Substrate

Abl Cytosolic Substrate is a substrate for Abelson tyrosine kinase (Abl ).

Ac-Tyr(PO3H2)-Glu-Glu-Ile-Glu-OH

Ac-Tyr(PO3H2)-Glu-Glu-Ile-Glu-OH is a high-affinity pentapeptide to bind to the src SH2 domain (IC50≈1 µM).

p60c-src substrate II

p60c-src substrate II is an efficient pentapeptide substrate for the tyrosine kinase pp60c-src.

  Catalog
Abmole Inhibitor Catalog




Keywords: PD173955 supplier, Src-bcr-Abl, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.